相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting
Marie Morille et al.
BIOMATERIALS (2010)
Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes
Huan Xu et al.
BIOMATERIALS (2010)
Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer
Muhammad W. Saif et al.
CANCER INVESTIGATION (2010)
Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro
Young-Ii Jeong et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Nanoparticle albumin-bound (nab (TM))-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer
Javier Cortes et al.
EJC SUPPLEMENTS (2010)
Targeting of drugs and nanoparticles to tumors
Erkki Ruoslahti et al.
JOURNAL OF CELL BIOLOGY (2010)
The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting
Yong-Il Chung et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Development of a highly stable and targetable nanoliposomal formulation of topotecan
Daryl C. Drummond et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Targeting nanoparticles to cancer
M. Wang et al.
PHARMACOLOGICAL RESEARCH (2010)
Non-viral nanosystems for systemic siRNA delivery
Stephanie David et al.
PHARMACOLOGICAL RESEARCH (2010)
Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise
Dhruba J. Bharali et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Novel Drug Delivery Systems for Sustained and Targeted Delivery of Anti-Cancer Drugs: Current Status and Future Prospects
Puneet Utreja et al.
Current Drug Delivery (2010)
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
Shyh-Dar Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan
Yan Sheng et al.
BIOMATERIALS (2009)
Nanoparticles in cellular drug delivery
Amir H. Faraji et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
Preclinical and clinical studies of anticancer agent-incorporating polymer micelles
Yasuhiro Matsumura et al.
CANCER SCIENCE (2009)
Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies
William C. Zamboni et al.
CLINICAL CANCER RESEARCH (2009)
Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
W. C. Zamboni et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer
Xiaoqian Shan et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2009)
In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles
George Mattheolabakis et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Vladimir Torchilin
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
H. Maeda et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Nanoparticle-based targeted drug delivery
Rajesh Singh et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Teni Boulikas
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting
M. Morille et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Synthesis and pH-dependent micellization of diblock copolymer mixtures
K. Van Butsele et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2009)
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts
Michel Vert
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2009)
Antibody-Conjugated Nanoparticles for Biomedical Applications
Manuel Arruebo et al.
JOURNAL OF NANOMATERIALS (2009)
Poly(ε-caprolactone)/Poly(ethylene glycol)/Poly(ε-caprolactone) Nanoparticles: Preparation, Characterization, and Application in Doxorubicin Delivery
MaLing Gou et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Emily Gullotti et al.
MOLECULAR PHARMACEUTICS (2009)
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Jason Park et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Tsutomu Ishihara et al.
PHARMACEUTICAL RESEARCH (2009)
Comparison of the PLA-mPEG and mPEG-PLA-mPEG copolymers nanoparticles on the plasma protein adsorption and in vivo biodistribution
Xiaoqian Shan et al.
SOFT MATTER (2009)
Advances of Cancer Therapy by Nanotechnology
Xu Wang et al.
CANCER RESEARCH AND TREATMENT (2009)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Protein nanoparticles as drug carriers in clinical medicine
Michael J. Hawkins et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Marie Morille et al.
BIOMATERIALS (2008)
Metastatic breast cancer: The role of pegylated liposomal doxorubicin after conventional anthracyclines
Shailendra Verma et al.
CANCER TREATMENT REVIEWS (2008)
Polymers and nanoparticles: Intelligent tools for intracellular targeting?
M. Breunig et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Particle size-dependent triggering of accelerated blood clearance phenomenon
Hiroyuki Koide et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Tatsuhiro Ishida et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery
Zhiyuan Hu et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2008)
Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors
Murugesan Senthilkumar et al.
JOURNAL OF DRUG TARGETING (2008)
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Kathleen F. Pirollo et al.
TRENDS IN BIOTECHNOLOGY (2008)
New frontiers in nanotechnology for cancer treatment
Frank Alexis et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Clinical pharmacology of liposomal anthracyclines: Focus on pegylated liposomal doxorubicin
Rebecca Solomon et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
Keun Seok Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Functional amphiphilic and biodegradable copolymers for intravenous vectorisation
K. Van Butsele et al.
POLYMER (2007)
Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts
William C. Zamboni et al.
CLINICAL CANCER RESEARCH (2007)
Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells
Tao Yang et al.
PHARMACEUTICAL RESEARCH (2007)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Active targeting of brain tumors using nanocarriers
Arnaud Beduneau et al.
BIOMATERIALS (2007)
Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines
Tamer A. Elbayoumi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy
Yuancai Dong et al.
BIOMATERIALS (2007)
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery
Lilian E. van Vlerken et al.
PHARMACEUTICAL RESEARCH (2007)
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Evangelos C. Gryparis et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice
Bhawna Gupta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Petra Kocbek et al.
JOURNAL OF CONTROLLED RELEASE (2007)
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
T. Hamaguchi et al.
BRITISH JOURNAL OF CANCER (2007)
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation
Tao Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding
Nancy Dos Santos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
ABA and BAB type triblock copolymers of PEG and PLA: A comparative study of drug release properties and stealth particle characteristics
Guosen He et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle
Wei Lu et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells:: Role of apolipoproteins in receptor-mediated endocytosis
Hyun R. Kim et al.
BIOMACROMOLECULES (2007)
Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells
H. Ryoung Kim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery
Jianjun Cheng et al.
BIOMATERIALS (2007)
10-Hydroxycamptothecin loaded nanoparticles: Preparation and antitumor activity in mice
Leyang Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes
XinYu Wang et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines
Khaled Greish
JOURNAL OF DRUG TARGETING (2007)
Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer
S. C. White et al.
BRITISH JOURNAL OF CANCER (2006)
Pegylated nanocapsules produced by an organic solvent-free method:: Evaluation of their stealth properties
Arnaud Beduneau et al.
PHARMACEUTICAL RESEARCH (2006)
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
Leonard G. Presta
ADVANCED DRUG DELIVERY REVIEWS (2006)
Parameters influencing the stealthiness of colloidal drug delivery systems
Arnaud Vonarbourg et al.
BIOMATERIALS (2006)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
OC Farokhzad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors
MN Khalid et al.
PHARMACEUTICAL RESEARCH (2006)
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes
A Judge et al.
MOLECULAR THERAPY (2006)
Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity
JH Park et al.
BIOMATERIALS (2006)
Influence of polysaccharide coating on the interactions of nanoparticles with biological systems
C Lemarchand et al.
BIOMATERIALS (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
K Temming et al.
DRUG RESISTANCE UPDATES (2005)
Long-circulating polymeric nanovectors for tumor-selective gene delivery
S Kommareddy et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2005)
Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles
M Huang et al.
ACTA PHARMACOLOGICA SINICA (2005)
Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic
XB Xiong et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
H Uchino et al.
BRITISH JOURNAL OF CANCER (2005)
A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization
SR Popielarski et al.
BIOCONJUGATE CHEMISTRY (2005)
Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy:: In vitro and in vivo
XB Xiong et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Aptamers as tools for target validation
M Blank et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine)
B Romberg et al.
BIOCONJUGATE CHEMISTRY (2005)
Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid
SC Semple et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Pegylated liposomal doxorubicin: Optimizing the dosing schedule in ovarian cancer
PG Rose
ONCOLOGIST (2005)
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Otilia M. Koo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2005)
Role of pegylated liposomal doxorubicin in ovarian cancer
JT Thigpen et al.
GYNECOLOGIC ONCOLOGY (2005)
Folate receptor targeted biodegradable polymeric doxorubicin micelles
HS Yoo et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice
LY Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Y Matsumura et al.
ANNALS OF ONCOLOGY (2004)
Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
F Marcucci et al.
DRUG DISCOVERY TODAY (2004)
Novel long-circulating lipid nanocapsules
D Hoarau et al.
PHARMACEUTICAL RESEARCH (2004)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
Polysaccharide-decorated nanoparticles
C Lemarchand et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Use of liposomal anthracyclines in Kaposi's sarcoma
SE Krown et al.
SEMINARS IN ONCOLOGY (2004)
Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
T Hamaguchi et al.
CANCER SCIENCE (2004)
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Y Matsumura et al.
BRITISH JOURNAL OF CANCER (2004)
Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management
ETH Yeh et al.
CIRCULATION (2004)
Nanopartide-aptamer bioconjugates: A new approach for targeting prostate cancer cells
OC Farokhzad et al.
CANCER RESEARCH (2004)
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim et al.
CLINICAL CANCER RESEARCH (2004)
Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles
C Chauvierre et al.
PHARMACEUTICAL RESEARCH (2003)
Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel
ML Immordino et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Drug delivery and transport to solid tumors
SH Jang et al.
PHARMACEUTICAL RESEARCH (2003)
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles
K Avgoustakis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Accelerated clearance of PEGylated liposomes in rats after repeated injections
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Surface-engineered nanoparticles for multiple ligand coupling
R Gref et al.
BIOMATERIALS (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity
JM Metselaar et al.
BIOCONJUGATE CHEMISTRY (2003)
Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting
I Brigger et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Therapeutic synthetic polymers: a game of Russian roulette?
AC Hunter et al.
DRUG DISCOVERY TODAY (2002)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
Nanocrystal targeting in vivo
ME Åkerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A Phase I study of SPI-077 (Stealth® liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer
DI Rosenthal et al.
INVESTIGATIONAL NEW DRUGS (2002)
Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent:: Pharmacokinetics and distribution of doxorubicin in brain and other tissues
GP Zara et al.
JOURNAL OF DRUG TARGETING (2002)
Paclitaxel and its formulations
AK Singla et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin
JMM Terwogt et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
ES Kim et al.
LUNG CANCER (2001)
Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge
Y Yamamoto et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery
P Calvo et al.
PHARMACEUTICAL RESEARCH (2001)
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
Z Panagi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon
MA Konerding et al.
BRITISH JOURNAL OF CANCER (2001)
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
SC Kim et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Role of formulation vehicles in taxane pharmacology
L van Zuylen et al.
INVESTIGATIONAL NEW DRUGS (2001)
A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin
GJ Veal et al.
BRITISH JOURNAL OF CANCER (2001)
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats
YP Li et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Phase I-II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
KJ Harrington et al.
ANNALS OF ONCOLOGY (2001)
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation
HM Redhead et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer
MR Ranson et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy
AA Gabizon
CANCER INVESTIGATION (2001)
New approaches to antibody therapy
LM Weiner et al.
ONCOGENE (2000)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):: influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
R Gref et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2000)
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin:: Pharmacokinetics and tissue distribution after i.v. administration to rats
A Fundarò et al.
PHARMACOLOGICAL RESEARCH (2000)
Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes
P Crosasso et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats
V Podio et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
